Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

+63 919 076 9100

All Products (153)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type	Inquiry
NX-5948 (BTK Degrader)	Targeted Protein Degrader	Hematologic
Molecule NX-5948 (BTK Degrader) Therapeutic Category Targeted Therapy (Investigational) Oncology Type Hematologic Drug Class / Mechanism Targeted Protein Degrader
LY3410738 (IDH1/2 Inhibitor)	IDH1/2 Inhibitor	Hematologic (AML)
Molecule LY3410738 (IDH1/2 Inhibitor) Therapeutic Category Targeted Therapy Oncology Type Hematologic (AML) Drug Class / Mechanism IDH1/2 Inhibitor
PF-06821497 (EZH2 Inhibitor)	EZH2 Inhibitor	Hematologic
Molecule PF-06821497 (EZH2 Inhibitor) Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism EZH2 Inhibitor
CPI-1205 (EZH2 Inhibitor)	EZH2 Inhibitor	Hematologic
Molecule CPI-1205 (EZH2 Inhibitor) Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism EZH2 Inhibitor
Guadecitabine	Hypomethylating / Investigational Agent	Hematologic (MDS/AML)
Molecule Guadecitabine Therapeutic Category Targeted Therapy (Investigational) Oncology Type Hematologic (MDS/AML) Drug Class / Mechanism Hypomethylating / Investigational Agent
Fostamatinib	SYK / Multi-Kinase Inhibitor	Hematologic
Molecule Fostamatinib Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism SYK / Multi-Kinase Inhibitor
Cerdulatinib	SYK / Multi-Kinase Inhibitor	Hematologic
Molecule Cerdulatinib Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism SYK / Multi-Kinase Inhibitor
Entospletinib	SYK / Multi-Kinase Inhibitor	Hematologic
Molecule Entospletinib Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism SYK / Multi-Kinase Inhibitor
Lanraplenib	SYK / Multi-Kinase Inhibitor	Hematologic
Molecule Lanraplenib Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism SYK / Multi-Kinase Inhibitor

NX-5948 (BTK Degrader) Targeted Therapy (Investigational)
Therapeutic Category Targeted Therapy (Investigational) Oncology Type Hematologic Drug Class / Mechanism Targeted Protein Degrader
LY3410738 (IDH1/2 Inhibitor) Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (AML) Drug Class / Mechanism IDH1/2 Inhibitor
PF-06821497 (EZH2 Inhibitor) Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism EZH2 Inhibitor
CPI-1205 (EZH2 Inhibitor) Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism EZH2 Inhibitor
Guadecitabine Targeted Therapy (Investigational)
Therapeutic Category Targeted Therapy (Investigational) Oncology Type Hematologic (MDS/AML) Drug Class / Mechanism Hypomethylating / Investigational Agent
Fostamatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism SYK / Multi-Kinase Inhibitor
Cerdulatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism SYK / Multi-Kinase Inhibitor
Entospletinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism SYK / Multi-Kinase Inhibitor
Lanraplenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism SYK / Multi-Kinase Inhibitor

‹ 1 … 11 12 13 ›